Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
AMAG Pharmaceuticals (NASDAQ: AMAG ) announces the initiation of a leadership transition, the decision to divest Intrarosa and Vyleesi and financial updates. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
Initiating CEO transition plan Divesting Intrarosa ® and Vyleesi ® 2020 financial guidance reflects reduction in annual operating expenses of more than $100M and a return to positive adjusted EBITDA WALTHAM, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- AMAG ...
WALTHAM, Mass., Jan. 03, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present at the 38 th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time), in San Fran...
WALTHAM, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- As part of the company’s ongoing support of research to reduce preterm birth and preeclampsia and associated complications, AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has awarded four grants totaling nearly $300,000 ...
AMAG Pharmaceuticals, Inc. (AMAG) Q3 2019 Earnings Conference Call November 01, 2019 8:00 AM ET Company Participants Linda Lennox - Vice President, Investor Relations Bill Heiden - President & Chief Executive Officer Julie Krop - Chief Medical Officer Tony Casciano - Chief ...
AMAG Pharmaceuticals ( AMAG ) Q3 results : Revenues: $84.1M (-31.2%); Feraheme: $44.2M (+19.5%); Makena: $34.3M (-57.2%); Intrarosa: $5.6M (+12.0%). More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
AMAG Pharmaceuticals (NASDAQ: AMAG ): Q3 GAAP EPS of -$0.70 beats by $0.09 . More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Commercial products achieve strong revenue and market share performance Vyleesi™ (bremelanotide injection) launched nationally in September Committed to work with the FDA to keep Makena available for at-risk pregnant women Conference call scheduled for 8:00 a.m. ET...
ABBV , ABR , AIG , AMAG , ASIX , AXL , BABA , BAH , BGG , CBOE , CCJ , CL , CVX , D , FND , FTS , GSHD , HAE , HE , HMSY , HRC , IBP , IMGN , IMO , ITT , LNG , LYB , MD , MGI , MGLN , MOG.A , NWL , OPI , PBA , PNM , POR , ROLL , RUTH , SRE , STX , TP...
News, Short Squeeze, Breakout and More Instantly...
AMAG Pharmaceuticals Inc. Company Name:
AMAG Stock Symbol:
NASDAQ Market:
AMAG Pharmaceuticals Inc. Website:
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...